İli Ezgi Gökpınar, Gezdirici Alper, Di Pietro Erminia, Yergeau Christine, Braverman Nancy
Genetic Diseases Center, Başakşehir Çam and Sakura City Hospital, İstanbul, Turkey.
Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
Am J Med Genet A. 2022 Nov;188(11):3229-3235. doi: 10.1002/ajmg.a.62959. Epub 2022 Aug 20.
Rhizomelic chondrodysplasia punctata (RCDP) are a group of peroxisomal disorders caused by plasmalogen synthesis defects. Patients with RCDP present with rhizomelic short stature, characteristic punctate epiphyseal calcifications, congenital cataracts, severe intellectual disability, seizures, and facial dysmorphism. Pathogenic variants in AGPS result in RCDP type 3 (RCDP3) which is an extremely rare disorder characterized by isolated ADHAPS deficiency. Six patients with RCDP3 have been identified, upto-date. We report two new patients with RCDP3 and their novel variants, c.154dupG (p.Ala52GlyfsTer6) and c.637+1G>A, in the AGPS gene. We also present a review of previously reported RCDP3 patients.
肢根型点状软骨发育不良(RCDP)是一组由缩醛磷脂合成缺陷引起的过氧化物酶体疾病。RCDP患者表现为肢根型身材矮小、特征性点状骨骺钙化、先天性白内障、严重智力障碍、癫痫发作和面部畸形。AGPS基因的致病变异导致3型RCDP(RCDP3),这是一种极为罕见的疾病,其特征为孤立性醛脱氢酶相关蛋白缺乏症。截至目前,已确诊6例RCDP3患者。我们报告了2例新的RCDP3患者及其在AGPS基因中的新变异,即c.154dupG(p.Ala52GlyfsTer6)和c.637+1G>A。我们还对先前报道的RCDP3患者进行了综述。